Medical Policies
- Alphabetical
-
Administrative Anesthesiology Allergy/Immunology Behavioral Health Cardiovascular Dermatology Durable Medical Equipment (DME) Ear, Nose, and Throat (ENT) Endocrinology Gastroenterology General Surgery Genetics Genitourinary Hematology/Oncology Infectious Diseases Laboratory/Pathology Nephrology Neurology/Neurosurgery Obstetrics and Gynecology Ophthalmology Oral maxillofacial Orthopedic Pediatrics Pharmacy Physical Medicine Preventive Medicine Pulmonary Radiology, diagnostic Radiation Therapy Transplant Women's Health
Administrative
Reimbursement Policies
Pharmacy
Dental
New Policies
Updated Policies
Upcoming Policies
| Policy | Name | Effective Date | Updated | Review Date | |
|---|---|---|---|---|---|
| Hematology/Oncology | |||||
| MP-038 | Circulating Tumor DNA and Circulating Tumor Cells for Cancer Management (Liquid Biopsy) | April 10, 2021 | February 10, 2021 | February 10, 2022 | |
| MP-042 | Electric Tumor Treatment Field Therapy for the Treatment of Glioblastoma Multiforme | April 21, 2021 | April 21, 2021 | April 21, 2022 | |